Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 14:8:669846.
doi: 10.3389/fnut.2021.669846. eCollection 2021.

Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression

Affiliations
Review

Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression

Rita Businaro et al. Front Nutr. .

Abstract

Emerging evidence is showing nutrition as a crucial factor in the high prevalence and incidence of neurodegenerative mental disorders. Preventive interventions on neuroinflammation seem to be able to interfere with neurodegeneration. Supplementation of essential nutrients, such as long-chain-polyunsaturated fatty acids, vitamin E and mineral elements, may minimize inflammation, enhancing antioxidative defense, and lowering the risk and incidence of age-related diseases, such as cardiovascular diseases and neurodegenerative diseases. This manuscript reviews the current evidence on the role of neuroinflammation in the pathophysiology of neurodegenerative and mental disorders, and preventive strategies for food supplementation in these neuropsychiatric diseases. Dietary supplementation-based strategies have been demonstrated to be effective in subjects with mild cognitive impairment, while weaker results have been obtained in patients with advance neurodegenerative disease. Adjunctive supplementation has also been demonstrated to improve depression, this being of marked benefit considering the comorbidity between cognitive impairment/dementia and depression. Further research is needed to improve the prescriptive precision of supplementation in patients, and to better understand potential interactions with clinical and pharmacokinetic factors.

Keywords: brain health; depression; diet; gut-brain axis; neuroinflammation.

PubMed Disclaimer

Conflict of interest statement

JS has received either presentation honoraria, travel support, clinical trial grants, book royalties, or independent consultancy payments from: Integria Healthcare & MediHerb, Pfizer, Scius Health, Key Pharmaceuticals, Taki Mai, Fiji Kava, FIT-BioCeuticals, Blackmores, Soho-Flordis, Healthworld, HealthEd, HealthMasters, Kantar Consulting, Angelini Pharmaceuticals, Grunbiotics, Polistudium, Australian Natural Therapeutics Group, Research Reviews, Elsevier, Chaminade University, International Society for Affective Disorders, Complementary Medicines Australia, SPRIM, Terry White Chemists, ANS, Society for Medicinal Plant and Natural Product Research, Sanofi-Aventis, Omega-3 Center, the National Health and Medical Research Council, CR Roper Fellowship. EG has received grants or PhD fellowship support from Indena Italy SpA and Verdure Sciences. LB is employed in Polistudium, Italy, which received funds for editorial assistance from Angelini. GM has received either presentation honoraria, travel support, grants, or independent consultancy payments from Polistudium, Integria Healthcare, Qbiotics, Soho-Floris, and Pharmako Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Bell SM, Burgess T, Lee J, Blackburn DJ, Allen SP, Mortiboys H. Peripheral glycolysis in neurodegenerative diseases. Int J Mol Sci. (2020) 21:8924. 10.3390/ijms21238924 - DOI - PMC - PubMed
    1. World Alzheimer Report. (2018). Available online at: https://www.alzint.org/resource/world-alzheimer-report-2018/
    1. Chi S, Wang C, Jiang T, Zhu XC, Yu JT, Tan L. The prevalence of depression in alzheimer's disease: a systematic review and meta-analysis. Curr Alzheimer Res. (2015) 12:189–98. 10.2174/1567205012666150204124310 - DOI - PubMed
    1. Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, et al. . Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the cache county study. Int J Geriatr Psychiatry. (2008) 23:170–7. 10.1002/gps.1858 - DOI - PMC - PubMed
    1. Yang W, Li X, Pan KY, Yang R, Song R, Qi X, et al. . Association of life-course depression with the risk of dementia in late life: a nationwide twin study. Alzheimers Dement. (2021). [Epub ahead of print]. 10.1002/alz.12303 - DOI - PubMed